ESH eLearning

On-demand programme of the scientific sessions reserved to participants.
On-demand content of the scientific programme will be freely available to all on June 29th, 2026

MAIN SCIENTIFIC TOPICS

– MGUS
– Smouldering myeloma
– Characterising multiple myeloma
– Newly-diagnosed fit multiple myeloma patients
– Role of frailty for treatment decisions
– Personalising treatment in multiple myeloma
– Relapsed multiple myeloma
– Novel technologies for tailored treatment
– Amyloidosis and Waldenstrom’s Diseas

FACULTY MEMBERS:

Samer Al-Hadidi (Dallas, USA), Evren Alici (Stockholm), Kenneth C. Anderson (Boston, USA), Meral Beksac (Ankara), Françoise Bodere (Nantes), Rajshekhar Chakraborty (New York, USA), Luciano Costa (Birmingham, USA), Tom Cupedo (Rotterdam), Madhav Dhodapkar (Seattle, USA), Meletios Dimopoulos (Athens), Nico Gagelmann (Boston, USA), Morie Gertz (Rochester, USA), Hartmut Goldschmidt (Heidelberg), Jens Hillengass (Buffalo, USA), Martin Kaiser (London, UK), Ola Landgren (Miami, USA), Suzanne Lentzsch (New York, USA), Johan L. Lund (Stockholm), Elias Mai (Heidelberg), Sham Mailankody (New York, USA), Christina Messiou (Sutton, UK), Roberto Mina (Atlanta, USA), Mohammad Mohty (Paris), Ajay Nooka (Atlanta, USA), Alberto Orfao (Salamanca), Robert Orlowski (Houston, USA), Krina Patel (Houston, USA), Charlotte Pawlyn (London, UK), Karlo Perica (New York, USA), Klaus Podar (Krems), Marc-Steffen Raab (Heidelberg), Leo Rasche (Würzburg), Fredrik Schjesvold (Oslo), Stefan Schönland (Heidelberg), Sigrun Thorsteinsdottir (Copenhagen)

On-demand programme of the scientific sessions reserved to participants.
On-demand content of the scientific programme will be freely available to all on June 8^th, 2026

SCIENTIFIC TOPICS:

– Spectrum of CLL – one disease or more
– Richter transformation
– Drivers of disease progression – from genetics, epigenetics, and proteomics (complexity of the evolution)
– The microenvironment of CLL
– Time limited therapies: which combination? which duration? which markers to stop therapy?
– BTK inhibition or degradation?
– The new challenge: resistance to one or two inhibitor classes? – Double refractory CLL
– Future therapies, new compounds
– Directions and strategies to use the best agents in the optimal way: sequencing, combinations, costs of therapy, availability

FACULTY MEMBERS:

Andreas Agathangelidis (Athens), Othman Al-Sawaf (Cologne), Julia Almeida (Salamanca), Daniel Bachurski (Cologne), Davide Bagnara (Genoa), Jennifer Brown (Boston), Shih-Shih Chen (Manhasset), Paula Cramer (Cologne), Matthew Davids (Boston), Peter Dreger (Heidelberg), Barbara Eichhorst (Cologne), Lukas Frenzel (Cologne), Paolo Ghia (Milan), Romain Guièze (Clermont Ferrand), Michael Hallek (Cologne), Marco Haselager (Amsterdam), Adam Kittai (New York), Jean Lemoine (Philadelphia), Talha Munir (Leeds), Ferran Nadeu (Barcelona), Sameer Parikh (Rochester), Alan Ramsay (London), Kerry Rogers (Columbus), Davide Rossi (Bellinzona), Jessica Schmidt (Würzburg), Christof Schneider (Ulm), Martina Seiffert (Heidelberg), Sigrid Skanland (Oslo), Justin Taylor (Miami), Alessandra Tedeschi (Milan), William Wierda (Houston)

On-demand programme of the scientific sessions reserved to participants.
​On-demand Industry Symposia already freely accessible after login.
On-demand content of the scientific programme will be freely available to all on June 1^st, 2026.

 

MAIN SCIENTIFIC TOPICS:

• DILEMMAS IN ACUTE LEUKAEMIAS
• NOVEL TREATMENTS
• DIAGNOSIS AND TREATMENT OF RARE DISEASES AND RARE SUBSETS
• MRD A PROPER SURROGATE ENDPOINT IN AML
• OPTIMIZING OUTCOMES IN ACUTE LEUKAEMIAS USING SUPPORTIVE STRATEGIES
• IMMUNE TARGETING STRATEGIES IN ALL
• REAL-WORLD AML THERAPY
• BLINA-TKI IS ENOUGH TO CURE PH-POSITIVE ALL
• HSC TRANSPLANTATION
• LEUKAEMIA TREATMENT CHALLENGES

FACULTY MEMBERS:

Ibrahim Aldoss (Duarte), Nicolas Boissel (Paris), Thomas Cluzeau (Nice), Charles Craddock (Birmingham), Anjali Cremer (Frankfurt), Stéphane de Botton (Villejuif), Eric Deconinck (Besançon), Courtney DiNardo (Houston), Shira Dinner (Chicago), Hervé Dombret (Paris), Harry Erba (Durham), Nicola Stefano Fracchiolla (Milan), Nicola Gökbuget (Frankfurt), Michael Heuser (Halle), Heidi Klepin (Winston Salem), Michael Kühn (Mainz), Sören Lehmann (Stockholm), Selina Luger (Philadelphia), Marlise Luskin (Boston), Jean-Baptiste Micol (Villejuif), Pau Montesinos (Valencia), Mariam Nawas (Chicago), Victoria Potter (London), Keith Pratz (Philadelphia), Christian Recher (Toulouse), Josep-Maria Ribera (Barcelona), Christoph Röllig (Dresden), Matthias Stelljes (Münster), Wendy Stock (Chicago), Richard Stone (Boston), Marion Strullu (Paris), David Teachey (Philadelphia), Geoffrey Uy (St Louis), Jurjen Versluis (Rotterdam), Eunice Wang (Buffalo), Matthew Joseph Wieduwilt (Winston Salem)

On-demand programme freely available after login.

MAIN SCIENTIFIC TOPICS:

• PREDISPOSITION AND AGING
• CLONAL HEMATOPOIESIS
• TARGETING CLONAL HEMATOPOIESIS
• THERAPEUTIC TARGETING 1
• METABOLIC AND PROTEOMIC ALTERATIONS
• CELLULAR THERAPY
• THERAPEUTIC TARGETING 2
• MEASURABLE RESIDUAL DISEASE IN AML
• THERAPEUTIC TARGETING 3
• THERAPEUTIC TARGETING 4

FACULTY MEMBERS:

Kelly BOLTON (St Louis), Steven CHAN (Toronto), Simona COLLA (Houston), Charles CRADDOCK (Birmingham), Ruud DELWEL (Rotterdam), Courtney DiNARDO (Houston), John DiPERSIO (St. Louis), Hartmut DÖHNER (Ulm), Konstanze DÖHNER (Ulm), Benjamin EBERT (Boston), Brunangelo FALINI (Perugia), Saar GILL (Philadelphia), Christopher HOURIGAN (Washington), Gerwin HULS (Groningen), Brian HUNTLY (Cambridge), Siddartha JAISWAL (Stanford), Courtney JONES (Cincinnati), Marina KONOPLEVA (New York), Andrew LANE (Boston), Bob LÖWENBERG (Rotterdam), Els MANSELL (Rotterdam), Markus MANZ (Zürich), Adam MEAD (Oxford), Eirini PAPAPETROU (New York), Alexandre PUISSANT (Paris), Eytan STEIN (New York), Zuzana TOTHOVA (Boston), Peter VALK (Rotterdam), Paresh VYAS (Oxford), Andrew WEI (Melbourne), Marcin WLODARSKI (Memphis), Sebastian WOLF (Frankfurt), Joshua ZEIDNER (Chapel Hill)

On-demand programme freely available after login.

MAIN SCIENTIFIC TOPICS:

– Stem Cells
– Cell biology
– Biomarkers, resistance and new targets
– New drugs and clinical trials
– CML special scenarios
– Myeloproliferative Neoplasms 
– Mitochondria biology
– Clonal tracking
– Treatment free remission
– Immunology

FACULTY MEMBERS:

Alexander ANDERSON (Tampa), Jane APPERLEY (London), Ravi BHATIA (Birmingham), Carla Maria BOQUIMPANI (Rio de Janeiro), Susan BRANFORD (Adelaide), Massimo BRECCIA (Rome), Tim BRÜMMENDORF (Aachen), Fausto CASTAGNETTI (Bologna), Ekaterina CHELYSHEVA (Moscow), Stefan CONSTANTINESCU (Brussels), Mhairi COPLAND (Glasgow), Jorge CORTES (Augusta), Antonio DE ALMEIDA (Lisbon), Michael DEININGER (Milwaukee), Hervé DOMBRET (Paris), Alessandro DONADA (Paris), Marieke ESSERS (Heidelberg), Briandy FERNANDEZ-MARRERO (El Paso), Robert Peter GALE (London), Payam GAMMAGE (Glasgow), Ian GANLEY (Dundee), François GUILHOT (Poitiers), Stein-Erik GULLAKSEN (Bergen), Olivier HANTSCHEL (Marburg), Vignir HELGASON (Glasgow), Andreas HOCHHAUS (Jena), Tim P. HUGHES (Adelaide), Henrike JACOBI (Aachen), Dan S. KAUFMAN (La Jolla), David KENT (York), Dennis KIM (Toronto), Takeshi KONDO (Sapporo), Daniela KRAUSE (Mainz), Elias LAGONIK (Adelaide), Fabian LANG (Frankfurt), Inga LESKE (Marburg), Ariel LEYTE-VIDAL (San Francisco), Weiming LI (Wuhan), Nienke LOKHORST (Nijmegen), François-Xavier MAHON (Bordeaux), Els MANSELL (Rotterdam), John MASCARENHAS (New York), Dragana MILOJKOVIC (London), Nirmalya Roy MOULIK (Mumbai), Satu MUSTJOKI (Helsinki), John Joson NG (Singapore), Vivian OEHLER (Seattle), Sin Tiong ONG (Singapore), Nicholas A. OTHIENO-ABINYA (Nairobi), Ilaria S. PAGANI (Adelaide), Paolo PICCALUGA (Bologna), Yasmine POBIEDONOSCEW (Bordeaux), Jerald RADICH (Seattle), Delphine REA (Paris), Tiffany RICKETTS (Birmingham), David ROSS (Adelaide), Daniele SARNELLO (Glasgow), Mirle SCHEMIONEK-REINDERS (Aachen), Micael SCHERER (Heidelberg), Mary SCOTT (Glasgow), Stephanie SEMBILL (Erlangen), Simona SOVERINI (Bologna), Kendra SWEET (Tampa), David VETRIE (Glasgow), Margherita VIERI (Aachen), Gerlinde WERNIG (Stanford), Deborah WHITE (Adelaide), Daniela ZACKOVA (Brno), Xiaoshuai ZHANG (Beijing)